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In order to study the metabolism of 13-cis-retinoic 
acid (13-cis-RA) in animal sebaceous glands and ana-
logues, preputial glands from normal and vitamin A-
deficient male rats were incubated with [3 H]13-cis-RA 
for up to 24 h; vitamin A-normal hamster costovertebral 
glands (flank organs) were incubated for 24 h as well . 
High-performance liquid chromatography was used to 
identify the metabolites. [3H]13-cis-RA was rapidly con-
verted to a less polar compound, [3H]all-trans-retinoic 
acid, by the preputial glands from both normal and 
deficient rats. In normal preputial glands, the level of 
[ 3 H ]all-trans-RA decreases and two more polar com-
pounds, metabolite I and [3H]4-keto-13-cis-RA appear. 
In contrast, [3 H]all-trans-RA is not metabolized further 
by the preputial glands from deficient rats, while [3 H] 
13-cis-RA in the hamster costovertebral glands remains 
intact for up to 24 h. The major metabolite of [3 H]l3-
cis-RA in rat preputial glands is [3H]4-keto-13-cis-RA. 
Initially, [3 H]13-cis-RA is converted to [3 H]all-trans-
RA. In vitamin A-deficient rats the preputial glands fail 
to further metabolize [3H]13-cis-RA to the more polar 
[ 3 H]13-cis-RA derivatives. This may be due to the re-
duced level of P-450 enzyme in vitamin A-deficient rat 
preputial glands. 
Recent clinical t rials have demonstrated the efficacy of 13-
cis-ret inoic acid (13-cis-RA) in the treatment of cystic acne and 
certain disorders of kerat inization [1- 5]. 13-cis-RA diminishes 
t he size and the function of sebaceous glands [6]. Although the 
metabolism of all -trans-retinoic acid (all -trans-RA) has been 
fairly well studied, only limited information is available on the 
metabolism of 13-cis-RA. Frolik and his coworkers [7] have 
identified 4-oxo-13-cis-RA as an in vitro (liver supernatant) 
and in vivo (plasma and liver samples) metabolite of 13-cis-RA 
in hamsters. Vane and Bugge have identified the same com-
pound as the major metabolite of 13-cis-RA in human blood 
(8]. . . 
In this study, we have investigated the m vttro metabolism 
of 13-cis-RA in two animal sebaceous structures, t he preputial 
gland, from normal and vitamin A-deficient male rats, and the 
metabolism of 13-cis-RA in costovertebral glands from vitamin 
A-normal hamsters. While 13-cis-RA metabolism can be stud-
ied in t hese structures, it is understood that these glands may 
not have the metabolic pathways present in human sebaceous 
glands and, furthermore, the differences between t he vitamin 
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A-sufficient and -deficient animal glands, in terms of the met-
abolic changes, may not be reflected in human sebaceous 
glands. 
MATERIALS AND METHODS 
Chemicals 
The reference retinoids were generous gifts from Hoffmann-La 
Roche Drug Compa ny, Nutley, New Jersey; ["H]13-cis-RA (1.56 Ci/ 
mmol) was purchased from SRJ Inte rnationa l, Men lo Park, California; 
Triton X-100 from Sigma Chemical Coyp., St. Louis, Missouri; Toluene, 
Norit A (cha rcoal) , and ether (anhydrous) from Baker Chem ical Co. , 
Phi llipsburg, New J ersey; omniflour from New England Nuclear, Bos-
ton , Massachusetts; Path-0-Cyte 5 from Miles Research Products, 
E lkha rt, India na; CMRL-1066 from Grand Island Biological Company, 
Grand Island, New York; L-ascorbic ac id from F isher Scientific Co., 
Fair Lawn, New Jersey; retinol acetate refe rence standard ampule from 
Eastman Kodak Co., Rochester, New York . Radioactive retinoid was 
stored in toluene at -70"C. Before use, t he to luene was blown off under 
nitrogen and RA purified every month by high-performance liquid 
chromatography (HPLC). 
A nimals and Diet 
Sprague-Dawley rats and hamsters were purchased from Charles 
River, Wilmington, Massachusetts; the vi tamin A-deficient diet from 
National B iochemicals, Clevela nd, Ohio; t he control d iet from Ralston 
Purina Compa ny, St. Louis, Missouri. 
The offspring of 10 pregnant female Sprague-Dawley rats were 
randomly assigned to two groups; one group was fed a vitam in A-
deficient diet for 8 weeks (Table I), t he other was fed a control diet 
(Purina Rodent Chow). Food and water were provided ad libitum. S ix 
male hamsters were put on t he control diet for 8 weeks. 
13-cis-RA (24 mg/ kg in 100 1-'1 sesame oil) or an equiva lent volume 
of placebo oi l was administered i.p. to adu lt ma le rats every third day 
for a period of 3 weeks. This t reatment was s imilar to that used by 
Gomez and Maskowitz (9]. 
Afte r 3 weeks of treatment t he a nima ls were sacrificed. The whole 
preputial gla nds were taken for histologic exam ination; fixed in 10% 
buffered neutral forma lin, and processed by rout ine histologic tech-
niques. Sections 6 I-'m in thickness were sta ined with hematoxylin a nd 
eosin. 
Assessment of Vitamin A Nutritional Status 
Blood and liver vitamin A con tent was determined by t he t rilluo-
roacet ic acid method of Dugan et a l [10] after extraction wit h ethyl 
ether by the method of Ames et al (11]. Rats were fed t he diet wi thout 
added vitamin A and were t hen kill ed afte r 8 weeks . T hey had no liver 
vitamin A stores, and t race serum levels of retinol. 
The preputia l glands of vitamin A-normal and -deficient, and 13-
cis-RA-treated rats, were histologically examined. As shown in F ig lA , 
t he ma le preputial gla nds from norma l rats t reated wit h placebo oil 
resembled the ones t reated with 13-cis-RA histologically (Fig 1B), being 
composed prima rily of glandular t issue prolife rating in a lobular fash-
ion, with small islands of squamous epit helium which occasiona lly 
formed ductlike structures. Preputial glands from vitamin A-deficien t 
rats (Fig ! C) were histo logica lly similar. However, the deficient rats' 
preput ial gla nds were one-half t he size of t he normal gla nds. In t he 
rats t reated with 13-cis-RA there was no difference in the size of t he 
preputia l glands when compared to glands from rats treated with 
placebo oil. 
Incubation Procedure 
Six male rats, 6 weeks old, from t he vita min A-normal and the 
vitamin A-deficient groups were kill ed under et hyl ether, and t he whole 
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TABLE I. Composition for vitamin A-deficient diets 
Ingredient 
Salt mi xture No. 2, U.S. P. XIII" 
Dried yeast (vi tamin D) 
Corn starch 
Vegetable oil 
Vi tamin free casein 
Viosterol 
Amount of ingredient 
4% 
8% 
65% 
5% 
18% 
11 mg/kg 
" Salt mixture- prepa re t he salt mixture speci!ied in the depletion 
diet as foll ows: 
Sodium chloride 
Potassium biphosphale 
Magnesium sulfate, a nhydrous 
Calcium ca rbonate 
Ferrous sulfate 
Ma nganese sulfate 
Potassium iodide 
Zinc sulfate 
Cupric sul fate 
Cobaltous chloride 
139.3 g 
389.0 g 
57.3 g 
381.4 g 
27.0 g 
4.01 g 
0.79 g 
0.548 g 
0.477 g 
0.023 g 
preputial glands, consisting of duct , ductal epit helium, inner alveolar 
t issue, and outer capsule connective t issue, approximately 0.78 g, were 
minced ove r ice a nd placed in a sterile petri dish conta ining 15 ml of 
medium (CMRL-1066) [1 2]; with crysta lline bovine insulin , 1 l'g/ml; 
hydrocort isone hemisuccinate, 0.1 l'g/ml; glu tamine, 2 mM ; penicillin 
100 U/ml ; st reptomycin, 100 l'g/ml ; 0.1- 0.2% Pat h-0-Cyte-5 bovine 
albumin and 0.25 - 0.5 mg/ml of L-ascorbic acid added. The addit ion of 
0.1- 0.2% Path-0 -Cyte-5 bovine a lbumin and 0.25- 0.5 mg/ml of L-
ascorbic ac id was found to be necessary to avoid nonspecific degrada-
tion of the ["H]RA in the aqueous medium over a 24-h period a nd had 
li ttle or no effect on the biologic activity of RA acid in vitro [13]. 
Labeled 13-cis- RA (3.98 X 10-8 M, approximately 480,000 cpm in 1:9 
DMSO and normal saline) [14] w::~s added to t he incubation mixture 
under red li ght. The petri dish was shaken by hand a nd cove red with 
aluminum foil to protect the ["H]13-cis-RA from light, then placed in 
a 3TC incubator. 
T he same procedure was repeated wi t h 0.5 g of hamster f1 ank organs 
and t he mixtures we re incubated for 24 h. 
Extraction Procedure 
At indicated t imes (3 .5, 12, 24 h) , 3 ml of t he incubation suspension 
was t ra nsferred in to a 15-ml centrifuge tube a nd mixed well wi t h 6 ml 
of ethyl ether (anhydrous). The tube was then stoppered tightly wit h a 
T enon cap, covered wi th a luminum foil , and shaken at 100 strokes per 
min fo r 20 min . It was t hen cent rifuged at 1000 rpm at room tempera-
ture for 10 min; then 5 ml of the ether layer was removed a nd was 
fil te red through a SEP-PAK cart ridge into a graduated cent rifuge t ube, 
dried under a stream of nit rogen, and 100 1'1 acetonitrile plus 10 1'1 of 
a mixture of cold carrier comprised of equal volumes of 10- 2 M of 13-
cis-RA, all -trans-RA, 4- keto-all -trans-RA, and 4-keto-13-cis-RA were 
added and the mixture was shaken well wi t h t he vortex. 
A nalysis of 13-cis- RA Metabolites by HPLC 
E xtracts were a nalyzed on a Waters HPLC syst em equipped wi t h a 
System Controller (model 270) , a n injector (model UGK), 2 Solvent 
Delivery Systems (M45), a UV absorbance detector (model 44-1, at 313 
nm), a steel Bondapak Cl 8 reverse phase column (3.9 nm IDX 30 em) , 
an in tegrator (Hewlett Packard model 3390A), a nd a fraction collector 
(G ilson model 201). The solvent system used was a mixture of aceton-
itrite a nd 1% ammonium acetate (80:20) [15,16]. 
RESULTS 
Rat Preputial Gland Incubations 
Identification and isolation of the in vitro metabolites of [3H] 
13-cis-RA was based on the retent ion time of the reference 
compounds and cochromatography wit h reference compounds. 
Approximately 95% of the radioactivity recovered from the 
control (media with no tissue) incubation sample was in the 
['1H]13-cis-RA elution area, indicating no spontaneous degra-
dation. 
After 3.5 h of incubation at 37°C, approximately 17% of the 
total radioactivity corresponding to [1H]13-cis-RA was ob-
served. Fifty-nine percent of the [3H]13-cis-RA was metabo-
lized to a less polar compound, which had the same retention 
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FIG 1. Preputial glands of normal male rat (A ), rat treated with 13-
cis -RA (B) , and vitamin A-deficient rat (C). 
time and cochromatographed with the reference alJ-trans-RA. 
Two more polar peaks were seen: one unidentified peak, des-
ignated as Met. I, and another metabolite which had the same 
retention time and cochromatographed with the standard 4-
oxo-13-cis-RA. These 2 compounds represented approximately 
23% of the total radioactivity recovered. 
After 12 h of incubation, approximately 20% of t he original 
CHJ13-cis-RA remained. The rest had been metabolized to [3H] 
all-trans-RA (less polar peak), representing approximately 33% 
of the total, and 2 more polar peaks, Met. I and [3H]4-oxo-13-
cis-RA. The more polar peak [3H)4-keto-13-cis-RA represented 
approximately 31% of the total radioactivity and the other peak 
(Met. I) represented approximately 16% of the total radioactiv-
ity. 
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After 24 h of incubation, approximately 8% of the starting 
compound e[3H]13-cis-RA) remained. The rest was converted 
to 2 more polar compounds ['1H]4-oxo-13-cis-RA, representing 
approximately 68% of the tota l and Met. I, representing ap-
proximately 13% of the total counts. The less polar peak, ['1H] 
all-trans-RA, represented approximately 10% of the total. 
In the preputial glands from vitamin A-deficient animals, the 
following results were observed. After 3.5 h of incubation at 
37oC approximately 23% of the total radioactivity correspond-
ing to ("H]13-cis-RA was found. Sixty-one percent of the [3H] 
13-cis-RA appeared as ['1H]all-trans-RA. Two polar peaks were 
observed: Met. I and [3H]4-oxo-13-cis-RA, representing ap-
proximately 15% of the total counts. 
After 12 h of incubation, approximately 21 % of the original 
[ ~H]13 -cis-RA remained. The rest was metabolized to [3H]all-
trans-RA (less polar peak), representing approximately 65% of 
the total. Two more polar peaks were observed: Met. I and [3H] 
4-oxo-13-cis-RA, together representing 14% of the total counts. 
After 24 h of incubation, approximately 19% of the compound 
["H]l3-cis-RA remained. The rest metabolized mainly to [3H] 
all-trans-RA, which represented approximately 57% of the 
total. The other peaks, Met. I and ["H]4-oxo-13-cis-RA repre-
sented about 24% of the total counts. These results were 
confirmed by cochromatography with actual standards and are 
summarized in Table II and Fig 2. 
The metabolism of ['1H]13-cis-RA in the hamster costo-
TABLE II. Time course of in vit ro metabolism of ( JH} 13-cis-RA in the preputial glands of normal a.nd vitamin A-deficient rats as slwwn in 
corresponding percentages of the metabolites" 
0 
ti 
~ 
~ 
5 
~ 
[ 
u 
3.5 Hours 12 Hours 24 Hours 
Compounds Normal Vitamin A- Normal Vitamin A- Normal Vitamin A-
rats deficient rats rats deficient rats rat.s deficient rats 
[31-1]13-cis-RA 17 23 20 21 8 19 
[ '1H]al J-tra.ns-RA 59 61 33 65 10 57 
[:JH]Met. I 13 8 16 7 13 10 
[:JI-1]4-keto-13-cis-RA 10 7 31 7 68 14 
a Values are represented in percentage of the total radioactivity. 
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F IG 2. HPLC profi les of in vitro me-
tabolism of (31-1]13-cis- RA preputia l 
glands. A, Normal p reputial gland incu-
bated 3.5 h. B, Vitamin A-deficient pre-
putial gland incubated for 3.5 h. C, Vi-
tamin A-normal preputial gland incu-
bated for 12 h. D, Vitamin A-deficient 
preputial gland incubated for 12 h. E, 
Vitam in A-normal preputial gland incu-
bated for 24 h. F, Vitamin A-deficient 
preputial gland incubated for 24 h. 
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FIG 3. HPLC analysis of in vitro metabolism of 13-cis-RA in ham-
ster costovertebral glands. The extract of a 24-h incubation was eluted 
isocratica lly using acetonitrile:! % ammonium acetate (80:20) gradient. 
vertebral gland (flank organ) in vitro for 24 h is shown in Fig 
3. As can be seen, [3H]13-cis-RA in the hamster flank organ 
remains intact for long periods of time (up to 24 h) . 
DISCUSSION 
The observation by Peck et a! [17] that recalcitrant cystic 
acne responds consistently and dramatically to oral 13-cis-RA 
is an exciting development in the treatment of acne. Histologic 
examinations of acne patients treated with 13-cis-RA reveal a 
considerable reduction in sebaceous gland size, and in fact the 
pilosebaceous unit is sometimes replaced by an epidermal cord 
[17] . In addition, treated patients have excessive epidermal 
scaling, and reduced numbers of nonintlamed lesions [18] . 
Furthermore, 13-cis-RA treatment in patients with nodular 
cystic acne has been shown to result in a long-lasting remission 
as well as a prolonged inhibition of sebum production. This is 
due to continued sebaceous gland inhibition [19]. Gomez and 
Maskowitz [9] have demonstrated that 13-cis-RA administra-
tion to male hamsters results in marked involution of the 
sebaceous glands of the flank organ. The mechanism of action 
for 13-cis-RA in inhibiting the function of sebaceous glands is 
not clear; however, in our studies 13-cis-RA did not affect the 
size or the histology of the rat preputial gland when adminis-
tered i.p. 24 mg/kg day for 3 weeks (Fig 1A, B). 
Hamster flank organs and rat preput ial glands have been 
~sed as animal models for human sebaceous glands; however, 
m many ways they are not comparable to human sebaceous 
glands. Furthermore, our results using these 2 model sebaceous 
structures are at variance and further confirm that the rat 
preputial gland is not a good model for human sebaceous gland 
function and metabolism. 
When we examined the metabolism of 13-cis-RA in both 
hamster flank organ and rat preputial gland, we found that 13-
cis-RA is rapidly catabolized in the rat preputial gland to more 
polar compounds that are known to be less biologically active 
while 13-cis-RA in the hamster flank organ remains intact fo; 
longer periods of time (up to 24 h) . Based on these observations 
it could be postulated that the more rapid catabolism of 13-cis-
RA in the preputial gland to less biologically active compounds 
m~y not allow 13-cis-RA to exert its full inhibitory effect on 
~h1s gland, _while in hamster flank organ the longer presence of 
mtact 13-cts-RA allows involution of that organ. 
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The rat preputial gland is, however, a good model to use to 
study the catabolism of 13-cis-RA, even though it did not 
involute in response to 3 weeks of 13-cis-RA treatment. The 
rat preputial gland is more active in metabolizing 13-cis-RA 
and therefore we were able to identify the major metabolic 
products of 13-cis-RA metabolism in this organ. 
I? the present study, 3.8 X 10-8 M [ 3H]13-cis-RA (14] was 
raptdly converted to [3H]all-trans-RA by the preputial glands 
from both normal and vitamin A-deficient rats. We used this 
dose arbitrarily, based on data from studies using hamster 
tissues [14,15]. Zile et al (20] found that all-trans-RA and 13-
cis-RA predominated in the intestinal mucosa of bile duct-
cannul~ted rats shortly after they had been injected intrajugu-
larly with purfied all-trans-RA. Isomerization of all-trans-RA 
to the 13-cis configurations has been reported to occur in vivo 
[21] and in vitro [22,23] . 
Based on our results, and other published studies [20-23] we 
propose a pathway for the metabolism of [3H]13-cis-RA in 
normal rat preputial glands and in vitamin A-deficient rat 
preputial glands (Fig 4). 
In the normal preputial gland, [3H]all-trans-RA formed from 
PH]13-cis-RA can be further metabolized to 2 or more polar 
compounds, Met. I and [3H]4-oxo-13-cis-RA. These results are 
in agreement with the findings in other tissues by other inves-
tigators (7,23], who demonstrated that 13-cis-RA in vitro and 
i~ vivo was metabolized to a common metabolite, 4-keto-13-
cts-RA. In our experiments, all-trans-RA was not metabolized 
further by the preputial glands from vitamin A-deficient rats 
after 24 h. These results are consistent with those of Napoli 
and McCormick [24], who showed that in vitamin A-deficient 
rats only RA supplementation accelerated RA metabolism and 
caused an accumulation of more polar metabolites. In another 
study, vitamin A-deficient rats showed a 6-h delay in excretion 
of radiolabeled vitamin in comparison with normal rats [25]. 
The plasma vitamin A turnover rate of rats fed sufficient 
vitamin A was significantly more rapid than the corresponding 
plasma vitamin A turnover rate in vitamin A-deficient rats 
(5.19 vs 1.98 JLg/h [26]). Vitamin A deficiency has been shown 
~o produce a reduction in several metabolic activities, such as 
m_the sulfation process (27], a decrease in hepatic gluconeogen-
esis [28], and a significant decrease in total carbohydrates and 
particularly in mannose, galactose, and sialic acid in the vita-
min A-deficient rat liver lysosomal membrane [29]. 
T?e pr_esent study has demonstrated that the preputial glands 
of VItamm A-deficient rats metabolize [3H]13-cis-RA to [3H} 
all-trans-RA during the first 24 h . However, there is little if 
an_y further metabolism to the more polar (3H]13-cis-RA deriv-
a~Ives: This may be due to a reduced level of P-450 enzyme in 
VItamm A-deficient rats. Siddkis et al [30] demonstrated that 
~ COOH ~COOH 
13-c is-RA All-trans-RA 
M(T I 
~ 
~OOH 
0 
4-oxo-13-cis-RA 
FIG 4. Proposed reaction pathway for the in vitro metabolism of 13-
cis-RA in rat preputial glands. The broken lines indicate the blockage 
that occurs in tl,le preputial glands of vitamin A-deficient rats. 
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hepatic cytochrome P-450 levels were significantly reduced in 
t he vitamin A-deficient animals. The metabolism of all-trans-
RA in vitro in hamster intestine and liver to 4-hydroxy-RA 
and then to 4-oxo-RA was inhibited by certain P -450 inhibitors 
[14]. 
Based on the resul ts of this study, we suggest t hat t issue-
specific effects of 13-cis-RA in animal model sebaceous glands 
may be regulated in part by the metabolism of 13-cis-RA such 
that different sebaceous gland responses may be elicited de-
pending upon the predominant 13-cis-RA metabolites present 
in t h e t issue. 
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